455 related articles for article (PubMed ID: 28240179)
21. Hypoxia-responsive nanocarriers for cancer imaging and therapy: recent approaches and future perspectives.
Thambi T; Park JH; Lee DS
Chem Commun (Camb); 2016 Jun; 52(55):8492-500. PubMed ID: 27225824
[TBL] [Abstract][Full Text] [Related]
22. Tumor microenvironment responsive nanocarriers for gene therapy.
Li Y; Tang K; Zhang X; Pan W; Li N; Tang B
Chem Commun (Camb); 2022 Aug; 58(63):8754-8765. PubMed ID: 35880654
[TBL] [Abstract][Full Text] [Related]
23. Smart Nanosized Drug Delivery Systems Inducing Immunogenic Cell Death for Combination with Cancer Immunotherapy.
Zhou L; Zhang P; Wang H; Wang D; Li Y
Acc Chem Res; 2020 Sep; 53(9):1761-1772. PubMed ID: 32819102
[TBL] [Abstract][Full Text] [Related]
24. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
25. Stimuli-responsive nanocarriers for drug delivery.
Mura S; Nicolas J; Couvreur P
Nat Mater; 2013 Nov; 12(11):991-1003. PubMed ID: 24150417
[TBL] [Abstract][Full Text] [Related]
26. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.
Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK
Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398
[TBL] [Abstract][Full Text] [Related]
27. Nanocarriers as an emerging platform for cancer therapy.
Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
[TBL] [Abstract][Full Text] [Related]
28. [Progress in dual-responsive nanocarriers based on acid sensitivity for anticancer drug].
Lu X; Guo X; Wan D; Pan J
Sheng Wu Gong Cheng Xue Bao; 2020 Sep; 36(9):1723-1731. PubMed ID: 33164451
[TBL] [Abstract][Full Text] [Related]
29. Advancements in pH-responsive nanocarriers: enhancing drug delivery for tumor therapy.
Chen Z; Wang X; Zhao N; Chen H; Guo G
Expert Opin Drug Deliv; 2023; 20(11):1623-1642. PubMed ID: 38059646
[TBL] [Abstract][Full Text] [Related]
30. Light-Responsive and Dual-Targeting Liposomes: From Mechanisms to Targeting Strategies.
Agiba AM; Arreola-Ramírez JL; Carbajal V; Segura-Medina P
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338380
[TBL] [Abstract][Full Text] [Related]
31. Tumor microenvironment-responsive micelles for pinpointed intracellular release of doxorubicin and enhanced anti-cancer efficiency.
Chen WL; Yang SD; Li F; Li JZ; Yuan ZQ; Zhu WJ; Liu Y; Zhou XF; Liu C; Zhang XN
Int J Pharm; 2016 Sep; 511(2):728-40. PubMed ID: 27484835
[TBL] [Abstract][Full Text] [Related]
32. Nucleic Acid-Based Functional Nanomaterials as Advanced Cancer Therapeutics.
Yuan Y; Gu Z; Yao C; Luo D; Yang D
Small; 2019 Jun; 15(26):e1900172. PubMed ID: 30972963
[TBL] [Abstract][Full Text] [Related]
33. Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions.
Raj R; Mongia P; Kumar Sahu S; Ram A
Curr Drug Targets; 2016; 17(2):206-28. PubMed ID: 26201484
[TBL] [Abstract][Full Text] [Related]
34. ZnO-based nanocarriers for drug delivery application: From passive to smart strategies.
Huang X; Zheng X; Xu Z; Yi C
Int J Pharm; 2017 Dec; 534(1-2):190-194. PubMed ID: 29038062
[TBL] [Abstract][Full Text] [Related]
35. Advance of DNA and CCPs-based nanocarriers in drug delivery systems.
Wu Y; Yao X; Chen Y; Li Y; Tian W
Biomed Mater Eng; 2017; 28(s1):S255-S261. PubMed ID: 28372302
[TBL] [Abstract][Full Text] [Related]
36. Carbohydrates based stimulus responsive nanocarriers for cancer-targeted chemotherapy: a review of current practices.
Zhang CW; Zhang JG; Yang X; Du WL; Yu ZL; Lv ZY; Mou XZ
Expert Opin Drug Deliv; 2022 Jun; 19(6):623-640. PubMed ID: 35611662
[TBL] [Abstract][Full Text] [Related]
37. Nanomaterial-Based Modulation of Tumor Microenvironments for Enhancing Chemo/Immunotherapy.
Le QV; Suh J; Oh YK
AAPS J; 2019 May; 21(4):64. PubMed ID: 31102154
[TBL] [Abstract][Full Text] [Related]
38. Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers.
Caldorera-Moore M; Guimard N; Shi L; Roy K
Expert Opin Drug Deliv; 2010 Apr; 7(4):479-95. PubMed ID: 20331355
[TBL] [Abstract][Full Text] [Related]
39. Intelligent nanomaterials for medicine: carrier platforms and targeting strategies in the context of clinical application.
Lehner R; Wang X; Marsch S; Hunziker P
Nanomedicine; 2013 Aug; 9(6):742-57. PubMed ID: 23434677
[TBL] [Abstract][Full Text] [Related]
40. Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms.
Kaushik N; Borkar SB; Nandanwar SK; Panda PK; Choi EH; Kaushik NK
J Nanobiotechnology; 2022 Mar; 20(1):152. PubMed ID: 35331246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
